Compagnie Lombard Odier SCmA - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$8,728,000
+51241.2%
829,681
+45993.4%
0.19%
Q4 2016$17,000
-5.6%
1,8000.0%0.00%
-100.0%
Q3 2016$18,000
+50.0%
1,8000.0%0.00%
Q2 2016$12,000
-25.0%
1,8000.0%0.00%
Q1 2016$16,000
-33.3%
1,8000.0%0.00%
-100.0%
Q4 2015$24,000
+26.3%
1,8000.0%0.00%0.0%
Q3 2015$19,000
-61.2%
1,8000.0%0.00%
-50.0%
Q2 2015$49,000
-10.9%
1,8000.0%0.00%0.0%
Q1 2015$55,0001,8000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,561,052$26,245,0005.86%
Palo Alto Investors LP 5,621,533$41,431,0003.20%
Iron Triangle Partners LP 2,000,000$14,740,0001.75%
Altium Capital Management LP 645,000$4,754,0001.59%
Birchview Capital, LP 269,332$1,985,0001.43%
Rubric Capital Management LP 3,607,443$26,587,0000.96%
Lombard Odier Asset Management (Switzerland) SA 776,053$5,720,0000.45%
RICE HALL JAMES & ASSOCIATES, LLC 1,344,929$9,912,0000.40%
Golden State Equity Partners 41,850$308,0000.16%
Hennion & Walsh Asset Management, Inc. 385,837$2,844,0000.15%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders